Amy Rabourn
2022
In 2022, Amy Rabourn earned a total compensation of $499.3K as Vice President of Finance at Rexahn Pharmaceuticals, a 50% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $91,000 |
|---|---|
| Option Awards | $114,751 |
| Salary | $260,000 |
| Other | $33,516 |
| Total | $499,267 |
Rabourn received $260K in salary, accounting for 52% of the total pay in 2022.
Rabourn also received $91K in non-equity incentive plan, $114.8K in option awards and $33.5K in other compensation.
Rankings
In 2022, Amy Rabourn's compensation ranked 4,346th out of 5,756 executives tracked by ExecPay. In other words, Rabourn earned more than 24.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,346 out of 5,756 | 25th |
Division Manufacturing | 2,443 out of 3,133 | 22nd |
Major group Chemicals And Allied Products | 1,182 out of 1,419 | 17th |
Industry group Drugs | 1,110 out of 1,320 | 16th |
Industry Pharmaceutical Preparations | 810 out of 966 | 16th |
Source: SEC filing on May 1, 2023.
Rabourn's colleagues
We found two more compensation records of executives who worked with Amy Rabourn at Rexahn Pharmaceuticals in 2022.